Keyphrases
Dose Escalation
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Radiation Dose
100%
Definitive Treatment
100%
Radiation Fractionation
100%
Patient Survival
66%
Boost Dose
66%
Disease Control
66%
Hyperfractionation
66%
Randomized Trial
33%
High Dose
33%
Overall Survival
33%
Positron Emission Tomography
33%
Long-term Survival
33%
Radiation Therapy
33%
Organs at Risk
33%
Four-dimensional Computed Tomography
33%
Stereotactic Body Radiation Therapy
33%
Concurrent Chemotherapy
33%
Local Control
33%
Tailored Treatment
33%
Radiation Therapy Oncology Group
33%
Anatomic Characteristics
33%
Technological Progress
33%
Metabolic Imaging
33%
Image Guidance
33%
Residual Disease
33%
Lung Toxicity
33%
Cardiovascular Toxicity
33%
Conventional Dose
33%
Hypofractionation
33%
Target Delineation
33%
Control Disease
33%
Extreme Hypofractionation
33%
Tumor Repopulation
33%
Moderate Hypofractionation
33%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Diseases
100%
Radiation Therapy
40%
Positron Emission Tomography
20%
Overall Survival
20%
Long Term Survival
20%
Drug Megadose
20%
Oncology
20%
Four Dimensional Computed Tomography
20%
Stereotactic Body Radiation Therapy
20%
Minimal Residual Disease
20%
Image-Guided Intervention
20%
Cardiovascular Toxicity
20%
Tumor Repopulation
20%
Lung
20%